Navigation Links
Sinovac Files Annual Report on Form 20-F
Date:4/30/2013

BEIJING, April 30, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccine products in China, announced today that it has filed its 2012 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2012 on April 30, 2013.  The Annual Report on Form 20-F is now available on the Company's website under SEC Filing in the Investor Relations section.

The Company will provide a hard copy of its complete audited financial statements to its shareholders upon request, free of charge.  Requests for a hard copy of the 2012 Annual Report can be made through the Contact IR page in the Investor Relations section of the Company's website by submitting complete mailing details on the request form.

About Sinovac
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies vaccine.  In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program.  The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program.  Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), pneumococcal conjugate, pneumococcal polysaccharides, varicella and rubella.  Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines. Sinovac was also granted a license to commercialize seasonal flu vaccine in Mexico.

Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Contact:
Helen Yang / Chris Lee
Sinovac Biotech Ltd. 
Tel:  +86-10-8279-9659/ 9696
Fax:  +86-10-6296-6910 
Email: ir@sinovac.com

Investors 
Stephanie Carrington 
The Ruth Group 
Tel: +1-646-536-7017 
Email: scarrington@theruthgroup.com

Media 
Victoria Aguiar 
The Ruth Group 
Tel: +1-646-536-7013 
Email: vaguiar@theruthgroup.com 


'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
2. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
3. Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
4. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
5. Sinovac Holds 2012 Annual General Meeting of Shareholders
6. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
7. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
8. Sinovac Schedules 2012 Annual Meeting of Shareholders
9. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
10. Sinovac Reports Unaudited First Quarter 2012 Financial Results
11. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... FRANCISCO, Calif. , Dec. 8, 2016 /PRNewswire/ ... technology to develop novel antiviral therapeutics, today announced ... as chief executive officer and a member of ... an incredibly experienced executive with a deep background ... Stephen Quake, D.Phil., founder of Agenovir, co-president of ...
(Date:12/8/2016)...  Haemonetics Corporation (NYSE: HAE ) has released ... innovative software suite designed to help customers drive efficiency in ... NextGen DMS 4 improves core features and introduces innovations aligned ... of plasma collected, enhancing quality and regulatory compliance and leveraging ... ...
(Date:12/8/2016)... 8, 2016 Henry Schein, Inc. (Nasdaq: ... and services to office-based dental, animal health and medical practitioners, ... in Marrodent, one of Poland,s largest ... This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks the Company,s ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is in ... Botelho advocates for the mass media launching of story movements to highlight what's ... share their unfortunate experiences; such a movement can generate the network power to ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dan Carlisle ... in Jefferson County, is announcing the launch of a charity drive to raise ... of homeless women and children in Birmingham has grown steadily since the 1980’s, ...
(Date:12/8/2016)... ... 08, 2016 , ... Coffey Agencies, a locally owned and ... in the northern Alabama and Georgia regions, is embarking on a charity drive ... has built a network of support and education facilities to develop and provide ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and mental ... mental health systems reform legislation in more than fifty years. We applaud the ... of our elected officials to improving mental health services and supports in our ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, an industry ... Control through a new partnership with Splashtop Inc. This remote control for Android ... to help businesses maximize their uptime and productivity. , Wavelink offers powerful enterprise ...
Breaking Medicine News(10 mins):